EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY-NC 4.0

Surfactant-Budesonide Combination to Prevent Death or Bronchopulmonary Dysplasia: A Systematic Review and Meta-Analysis

Ilari Kuitunen, Giulia Res, Kati Räsänen, Alessia Vassallo, Chiara Autilio, Maria Rosaria Gualano, Daniele De Luca

Neonatology · 25.04.2026 · 1-12

DOI: 10.1159/000552203 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Neonatology, online erschienen am 25.04.2026. Verfasst von Ilari Kuitunen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland, ilari.kuitunen@uef.fi. Hauptthemen laut MEDLINE: Bronchopulmonary Dysplasia, Budesonide, Pulmonary Surfactants. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Bronchopulmonary dysplasia (BPD) remains a major complication of prematurity. We aimed to assess whether intratracheal administration of budesonide mixed with surfactant reduces mortality and BPD in preterm infants.

Methods

We conducted a systematic review and meta-analysis of randomised and observational studies enrolling preterm neonates. PubMed, Scopus, and Web of Science were searched from inception to October 2025 without language or year restrictions. Studies comparing bolus administration of bovine or porcine surfactant mixed with budesonide versus surfactant alone were included. Random-effects meta-analyses using inverse variance weighting were performed to estimate risk ratios (RRs) with 95% confidence intervals (CIs). Certainty of evidence was assessed using GRADE.

Results

Twenty randomised and five observational studies were included. Surfactant-budesonide combination therapy reduced mortality (RR: 0.83, 95% CI: 0.69–0.99; 18 studies, 5,117 infants) and BPD (RR: 0.84, 95% CI: 0.75–0.94; 25 studies, 5,732 infants). Mortality reduction was observed when all studies were pooled, with no significant difference between study designs. Prenatal steroid exposure was associated with greater mortality reduction. Reduction in BPD remained significant when restricted to randomised trials, irrespective of surfactant type. Sensitivity analyses excluding studies at high risk of bias yielded similar results. Certainty of evidence was moderate for both outcomes.

Conclusion

Surfactant combined with budesonide may reduce mortality and BPD in preterm infants. However, the evidence remains insufficient to recommend the combination as generalised primary treatment for all preterm neonates. Future studies should incorporate pathophysiological phenotyping to identify infants most likely to benefit.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bronchopulmonary DysplasiaBudesonidePulmonary SurfactantsAnimalsHumansInfant, NewbornDrug Therapy, CombinationInfant, PrematureRandomized Controlled Trials as TopicObservational Studies as Topic

Stichwörter der Autor:innen

Bronchopulmonary dysplasiaMortalityNeonatePretermRespiratory distress

Substanzen

BudesonidePulmonary Surfactants

Autor:innen und Institutionen

  • Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland, ilari.kuitunen@uef.fi.
  • Department of Paediatrics and Neonatology, Kuopio University Hospital, Kuopio, Finland, ilari.kuitunen@uef.fi.
  • Division of Pediatrics and Neonatal Critical Care, "A. Béclère" Medical Center, Paris Saclay University Hospital, APHP, Paris, France.
  • Physiopathology and Therapeutic Innovation Unit, INSERM U999, Paris Saclay University, Paris, France.
  • Department of Paediatrics and Neonatology, Kuopio University Hospital, Kuopio, Finland.
  • Clinical Pathology and Microbiology Unit, St. Carlo Hospital, Potenza, Italy.

Zitieren

APA

Kuitunen, I., Res, G., Räsänen, K., Vassallo, A., Autilio, C., Gualano, M. R., & De Luca, D. (2026). Surfactant-Budesonide Combination to Prevent Death or Bronchopulmonary Dysplasia: A Systematic Review and Meta-Analysis. Neonatology, 1-12. https://doi.org/10.1159/000552203

Vancouver

Kuitunen I, Res G, Räsänen K, Vassallo A, Autilio C, Gualano MR, et al. Surfactant-Budesonide Combination to Prevent Death or Bronchopulmonary Dysplasia: A Systematic Review and Meta-Analysis. Neonatology. 2026:1-12. doi:10.1159/000552203

BibTeX
@article{Kuitunen2026,
  author = {Kuitunen, Ilari and Res, Giulia and Räsänen, Kati and Vassallo, Alessia and Autilio, Chiara and Gualano, Maria Rosaria and De Luca, Daniele},
  title = {Surfactant-Budesonide Combination to Prevent Death or Bronchopulmonary Dysplasia: A Systematic Review and Meta-Analysis},
  journal = {Neonatology},
  year = {2026},
  pages = {1--12},
  doi = {10.1159/000552203}
}
Kostenlos starten →